ZA9530B - Compositions for use in treating neurogenic inflammation - Google Patents

Compositions for use in treating neurogenic inflammation

Info

Publication number: ZA9530B
Authority: ZA; South Africa
Prior art keywords: compositions; neurogenic inflammation; treating neurogenic; treating; inflammation
Prior art date: 1994-01-04

Application number

ZA9530A

Inventor

Knud Erik Andersen

Uffe Bang Olsen

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-01-04

Filing date

1995-01-04

Publication date

1996-07-04

1995-01-04 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

1996-07-04 Publication of ZA9530B publication Critical patent/ZA9530B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)

ZA9530A 1994-01-04 1995-01-04 Compositions for use in treating neurogenic inflammation ZA9530B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DK2094		1994-01-04

Publications (1)

Publication Number	Publication Date
ZA9530B true ZA9530B (en)	1996-07-04

Family

ID=8088844

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9530A ZA9530B (en)	1994-01-04	1995-01-04	Compositions for use in treating neurogenic inflammation

Country Status (13)

Country	Link
EP (1)	EP0735872A1 (en)
JP (1)	JPH09507849A (en)
CN (1)	CN1142183A (en)
AU (1)	AU1311195A (en)
BR (1)	BR9506453A (en)
CA (1)	CA2180239A1 (en)
CZ (1)	CZ198396A3 (en)
FI (1)	FI962750L (en)
HU (1)	HUT76281A (en)
IL (1)	IL112223A0 (en)
NO (1)	NO962812L (en)
WO (1)	WO1995018615A1 (en)
ZA (1)	ZA9530B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997022342A1 (en) *	1995-12-15	1997-06-26	Novo Nordisk A/S	Novel method
US7417040B2 (en)	2004-03-01	2008-08-26	Bristol-Myers Squibb Company	Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2965639A (en) *		1960-12-20		New basically substituted azepine
FI864246A7 (en) *	1985-11-08	1987-05-09	Warner Lambert Co	N-SUBSTITUERADE 3-PIPERIDINE- ELLER 3-PYRIDINE CARBOXYLSYROR SAMT DERAS DERIVATS.
DK93791D0 (en) *	1991-05-17	1991-05-17	Novo Nordisk As	NEW HETEROCYCLIC CARBOXYLIC ACIDS

1995
- 1995-01-02 IL IL11222395A patent/IL112223A0/en unknown
- 1995-01-03 BR BR9506453A patent/BR9506453A/en not_active Application Discontinuation
- 1995-01-03 HU HU9601826A patent/HUT76281A/en unknown
- 1995-01-03 CZ CZ961983A patent/CZ198396A3/en unknown
- 1995-01-03 FI FI962750A patent/FI962750L/en not_active Application Discontinuation
- 1995-01-03 EP EP95904410A patent/EP0735872A1/en not_active Withdrawn
- 1995-01-03 WO PCT/DK1995/000003 patent/WO1995018615A1/en not_active Ceased
- 1995-01-03 CA CA002180239A patent/CA2180239A1/en not_active Abandoned
- 1995-01-03 CN CN95191801A patent/CN1142183A/en active Pending
- 1995-01-03 AU AU13111/95A patent/AU1311195A/en not_active Abandoned
- 1995-01-03 JP JP7518276A patent/JPH09507849A/en active Pending
- 1995-01-04 ZA ZA9530A patent/ZA9530B/en unknown
1996
- 1996-07-03 NO NO962812A patent/NO962812L/en unknown

Also Published As

Publication number	Publication date
BR9506453A (en)	1997-09-02
FI962750A7 (en)	1996-09-04
AU1311195A (en)	1995-08-01
HU9601826D0 (en)	1996-09-30
FI962750L (en)	1996-09-04
FI962750A0 (en)	1996-07-04
HUT76281A (en)	1997-07-28
EP0735872A1 (en)	1996-10-09
WO1995018615A1 (en)	1995-07-13
CA2180239A1 (en)	1995-07-13
JPH09507849A (en)	1997-08-12
IL112223A0 (en)	1995-03-30
CN1142183A (en)	1997-02-05
NO962812L (en)	1996-09-04
CZ198396A3 (en)	1997-01-15
NO962812D0 (en)	1996-07-03

Publication	Publication Date	Title
EG20753A (en)	2000-01-31	Synergistic composition
IL115891A0 (en)	1996-01-31	Hemorrhoidial compositions and their use
IL115693A0 (en)	1996-01-19	Cosmetic composition
GB9423952D0 (en)	1995-01-11	Cleaning compositions and their use
GB9414721D0 (en)	1994-09-07	Dentifrice composition
IL115766A0 (en)	1996-01-19	Composition and treatment for multiple sclerosis
HU9501088D0 (en)	1995-06-28	Improvements in general purpose cleaning compositions
ZA9510181B (en)	1997-05-30	Cosmetic composition
ZA974266B (en)	1998-11-16	Anti-vaginitis compositions for topical use
ZA914102B (en)	1993-02-24	Methods for treating inflammation and compounds and compositions suitable for use therein
GB9607963D0 (en)	1996-06-19	Cleansing composition
IL113661A0 (en)	1995-08-31	Compositions and treatment for multiple sclerosis
GB9422098D0 (en)	1994-12-21	Cosmetic composition
IL129446A0 (en)	2000-02-29	Compositions for use in concrete and concrete products obtained therefrom
IL111554A0 (en)	1995-03-30	Methods and compositions for hair treatment
GB9423234D0 (en)	1995-01-04	Cleaning compositions and their use
EP0835092A4 (en)	2000-05-10	Composition and treatment for baldness
GB9420616D0 (en)	1994-11-30	Method, compositions and use
GB9415623D0 (en)	1994-09-21	Improvements in oleaginous compositions
ZA9530B (en)	1996-07-04	Compositions for use in treating neurogenic inflammation
GB9525048D0 (en)	1996-02-07	Composition compound and use
GB9422099D0 (en)	1994-12-21	Cosmetic composition
GB9413076D0 (en)	1994-08-17	Composition and use
IL113444A0 (en)	1995-07-31	Compositions and methods for treating leukemia
GB9617346D0 (en)	1996-10-02	Therapeutic methods and compositions for use therein